Center for Vaccine Research
Friday, July 17, 2020
Proceeds from a new Pitt Athletics T-shirt are supporting the Center for Vaccine Research in its work developing a COVID-19 vaccine to emerge “Over Fate and Foe Victorious.”
Tuesday, July 14, 2020
Expert faculty members in the University of Pittsburgh’s School of Medicine are at the helm of a new COVID-19 Medical Response Office, which will oversee the implementation of a virus monitoring program on all five Pitt campuses. The program will direct the University’s COVID-19 testing, contact tracing, reporting procedures and isolation and quarantine protocols.
Friday, July 10, 2020
Through good times and bad, the University’s phones never stop ringing—ever wonder who answers? For two decades, it’s been Senior Switchboard Operator Lin Haberman and a small team. Learn how the calls have changed over the years and get a behind-the-scenes look at how COVID-19 is different from any other event the switchboard’s seen.
Tuesday, June 16, 2020
Federal funding is an important part of supporting research and innovation in universities. Pitt’s Evan Facher describes how the novel coronavirus could change the equation.
Monday, March 23, 2020
The Coalition for Epidemic Preparedness Innovations is committing nearly $5 million to a consortium that includes the University of Pittsburgh’s Center for Vaccine Research to develop a vaccine for the novel coronavirus.
Thursday, February 13, 2020
More than 250 people attended a panel discussion on Feb. 12 to hear a group of Pitt and county experts discuss the coronavirus outbreak.
Thursday, February 13, 2020
The University of Pittsburgh is among a select few institutions expected to receive samples of the coronavirus for study. In his remarks to the University Senate, Paul Duprex, director of the Center for Vaccine Research, highlighted the tremendous history the University has in working on vaccines and why this matters.
Friday, January 3, 2020
As part of the global push to prevent tuberculosis, Distinguished Professor JoAnne Flynn and a group of Pitt and National Institutes of Health researchers have discovered that intravenously injecting the standard tuberculosis vaccine could boost its power.
Tuesday, October 24, 2017
When a mysterious illness emerged in his Brazilian hometown, Pitt Public Health's Ernesto T.A. Marques mobilized with colleagues to decode its unknowns.